Carvajal, R. D., Butler, M. O., Shoushtari, A. N., Hassel, J. C., Ikeguchi, A., Hernandez-Aya, L., Nathan, P., Hamid, O., Piulats, J. M., Rioth, M., Johnson, D. B., Luke, J. J., Espinosa, E., Leyvraz, S., Collins, L., Goodall, H. M., Ranade, K., Holland, C., Abdullah, S. E., … Sato, T. (2022). Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial. Nature Medicine, 28(11), 2364–2373. https://doi.org/10.1038/s41591-022-02015-7
Columbia Affiliation:
Subjects:
Ocular Cancer Research and Treatment
(OpenAlex Topic)
Immunobiology of Dendritic Cells
(OpenAlex Topic)
Diagnosis and Treatment of Multiple Myeloma
(OpenAlex Topic)
Melanoma
(MeSH)
Uveal Neoplasms
(MeSH)
Publication Type:
Article
Unique ID:
10.1038/s41591-022-02015-7
PMID:
Journal:
Publication Date:
Data Source:
PubMed